BrainsWay Ltd (BRSYF PINK) stock market data APIs
$11.9628
0(0%)
as of March 24, 2026
Try our APIs with
free plan!
BrainsWay Ltd Financial Data Overview
Price chart is built with
Anychart
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Prev. Close
11.9628
Open
11.9628
High
11.9628
Low
11.9628
52 wk Range
3.26-11.87
Market Cap
532 M
P/E Ratio
64.1111
Shares Outstanding
40 033 K
Revenue
52 225 K
Beta
0.307
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BrainsWay Ltd data using free add-ons & libraries
Get BrainsWay Ltd Fundamental Data
BrainsWay Ltd Fundamental data includes:
- Net Revenue: 52 225 K
- EBITDA: 5 861 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BrainsWay Ltd News
New
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
BrainsWay BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain...
Middle East Hidden Gems Including Ayalon Insurance and 2 Promising Stocks
As Middle Eastern markets experience fluctuations due to weak oil prices and geopolitical tensions, investors are keenly observing the region's economic landscape for opportunities amid the challenges...
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
BrainsWay Optum Behavioral Health, a Health Services Company with Over 48 Million Covered Lives, Joins Growing List of Insurers Now Covering Deep TMS Depression Therapy for Adolescents Aged 15 and Ol...
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
BrainsWay Recent agreements withtwo additional U.S. mental health providersbring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
